Cytek Biosciences annual r&d spending
2020
2021
2022
2023
2024
2025
Cytek Biosciences R&D Spending Growth & History (CTKB)
Cytek Biosciences's r&d spending was $36.5M for fiscal 2025.
View full Cytek Biosciences company overviewCytek Biosciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $36.5M | −$2.9M | −7.45% |
| 2024 | 2024-12-31 | $39.4M | −$4.7M | −10.76% |
| 2023 | 2023-12-31 | $44.2M | $9.3M | +26.66% |
| 2022 | 2022-12-31 | $34.9M | $10.4M | +42.62% |
| 2021 | 2021-12-31 | $24.4M | $10.7M | +78.50% |
| 2020 | 2020-12-31 | $13.7M | — | — |
Cytek Biosciences quarterly r&d spending
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $9.7M | $915,000 | +10.37% |
| Q1 2026 | 2026-03-31 | $9.6M | −$121,000 | −1.24% |
| Q4 2025 | 2025-12-31 | $9.0M | −$762,000 | −7.84% |
| Q3 2025 | 2025-09-30 | $9.0M | −$926,000 | −9.37% |
| Q2 2025 | 2025-06-30 | $8.8M | −$1.2M | −11.75% |
| Q1 2025 | 2025-03-31 | $9.7M | −$71,000 | −0.72% |
| Q4 2024 | 2024-12-31 | $9.7M | −$1.1M | −10.55% |
| Q3 2024 | 2024-09-30 | $9.9M | −$1.3M | −11.54% |
| Q2 2024 | 2024-06-30 | $10.0M | −$2.1M | −17.59% |
| Q1 2024 | 2024-03-31 | $9.8M | −$178,000 | −1.78% |
| Q4 2023 | 2023-12-31 | $10.9M | $1.1M | +11.52% |
| Q3 2023 | 2023-09-30 | $11.2M | $2.5M | +29.14% |
| Q2 2023 | 2023-06-30 | $12.1M | $3.7M | +43.86% |
| Q1 2023 | 2023-03-31 | $10.0M | $1.9M | +24.29% |
| Q4 2022 | 2022-12-31 | $9.7M | $2.7M | +37.75% |
| Q3 2022 | 2022-09-30 | $8.7M | $2.6M | +42.32% |
| Q2 2022 | 2022-06-30 | $8.4M | $2.2M | +36.20% |
| Q1 2022 | 2022-03-31 | $8.0M | $2.9M | +57.54% |
| Q4 2021 | 2021-12-31 | $7.1M | — | — |
| Q3 2021 | 2021-09-30 | $6.1M | $2.7M | +80.04% |
| Q2 2021 | 2021-06-30 | $6.2M | $3.3M | +112.41% |
| Q1 2021 | 2021-03-31 | $5.1M | — | — |
| Q3 2020 | 2020-09-30 | $3.4M | — | — |
| Q2 2020 | 2020-06-30 | $2.9M | — | — |
Cytek Biosciences r&d spending trends
Over the last five fiscal years, Cytek Biosciences's r&d spending increased from $13.7M to $36.5M, a change of $22.8M. The latest reported quarter, Q2 2026, shows $9.7M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cytek Biosciences source filings ↗